Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

BUY
$224.99 - $256.14 $1,799 - $2,049
8 Added 36.36%
30 $7,000
Q1 2023

May 10, 2023

SELL
$239.75 - $277.0 $239 - $277
-1 Reduced 4.35%
22 $5,000
Q4 2022

Feb 01, 2023

SELL
$241.42 - $282.29 $42,731 - $49,965
-177 Reduced 88.5%
23 $6,000
Q3 2022

Nov 03, 2022

BUY
$247.06 - $1507.4 $6,917 - $42,207
28 Added 16.28%
200 $52,000
Q2 2022

Aug 09, 2022

SELL
$237.11 - $299.66 $9,721 - $12,286
-41 Reduced 19.25%
172 $44,000
Q1 2022

Apr 22, 2022

BUY
$257.27 - $315.76 $23,926 - $29,365
93 Added 77.5%
213 $62,000
Q4 2021

Jan 20, 2022

BUY
$292.08 - $329.01 $35,049 - $39,481
120 New
120 $39,000
Q3 2020

Nov 05, 2020

SELL
$177.16 - $215.33 $6,023 - $7,321
-34 Closed
0 $0
Q4 2019

May 19, 2020

BUY
$133.47 - $153.48 $4,537 - $5,218
34 New
34 $5,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Disciplined Investments, LLC Portfolio

Follow Disciplined Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investments, LLC with notifications on news.